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Summary
Objective: Human osteoarthritis (OA) is characterized by aggrecanase-mediated depletion of cartilage aggrecan. We have examined the
abundance, location and some biochemical properties of the six known aggrecanases (A disintegrin and metalloproteinase with thrombospondin-
like motifs 1 (ADAMTS1) 4, 5, 8, 9 and 15) in normal and OA human cartilages.
Methods: Formalin-ﬁxed, ethylenediamine tetraacetic acid (EDTA)-decalciﬁed sections of full-depth cartilage from human OA tibial plateaus
and normal control samples were studied by confocal imaging. Probes included speciﬁc antibodies to aggrecanases and two aggrecan
epitopes, as well as biotinylated hyaluronan binding protein (HABP) for hyaluronan (HA) visualization. Cartilage extracts were analyzed by
Western blot for the individual proteinases and aggrecan fragments.
Results: ADAMTS5 was present in association with cells throughout normal cartilage and was markedly increased in OA, particularly in clonal
groups in the superﬁcial and transitional zones, where it was predominantly co-localized with HA. Consistent with the confocal analysis, a high
molecular weight complex of ADAMTS5 and HA was isolated from human OA cartilage by isotonic salt extraction and chromatography on
Superose 6. The complex eluted with an apparent molecular size of about 2 106 and contained major ADAMTS5 forms of 150, 60, 40
and 30 kDa. The yield of most forms on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was markedly enhanced
by prior digestion of the complex with either Streptomyces hyaluronidase or chondroitinase ABC.
Conclusion: ADAMTS5 abundance and distribution in human OA cartilages is consistent with a central role for this enzyme in destructive
aggrecanolysis. HA-dependent sequestration of ADAMTS5 in the pericellular matrix may be a mechanism for regulating the activity of this
proteinase in human OA cartilage.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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SocietyIntroduction
Osteoarthritis (OA) of the human knee has been evaluated
by multiple criteria including pain1, plain radiograph2 and
delayed gadolinium-enhanced magnetic resonance imag-
ing of cartilage (dGEMRIC)3. Total joint replacement sur-
gery provides tissue samples which have been examined
by biochemical4e6, biomechanical7,8 and standard histopa-
thology9 methods. More recently, immunohistochemistry
(IHC) of proteins and in situ hybridization (ISH) of
m-RNA10e12 have added signiﬁcantly to our understanding
of the cellular pathways which are involved. For example,
IHC analysis of clonal nests in OA cartilages has shown
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including RAGE13, RUNX-2 and matrix metalloproteinase-
13 (MMP-13)14, tenascin15, annexin VIII16, caspases 3 and
917 and nitrotyrosine, which is indicative of oxidative stress18.
Phenotypic changes in these cells are further underscored
by ISH which reveals increased expression of aggrecan
core protein, link protein, osteopontin, collagen type II,
Bcl-2, Sox9, MMP-3, MMP-9, and MMP-1319. In another
study20, upregulation was observed for MMP-1, MMP-14
(MT1-MMP), A disintegrin and metalloproteinase with
thrombospondin-like motis 5 (ADAMTS5), IL-1, TNF-alpha,
COL10A1, MMP-9, MMP-13, Indian hedgehog and caspase
3, and a range of pro-apoptotic marker genes21. The mech-
anisms by which such extensive cellular changes come
together in uncontrolled tissue destruction in OA remain un-
clear, although it is reasonable to assume that unchecked
proteolytic cascades which fragment the aggrecan and col-
lagen components are central. In this regard it seems likely that
one or more of the aggrecanases (ADAMTS1, 4, 5, 8, 9, 15)19
720 A. Plaas et al.: ADAMTS5ehyaluronan complexes in OA cartilageare responsible for destructive aggrecanolysis and one
or more of the collagenases (MMP-1, 8, 13, 14) are respon-
sible for destructive collagenolysis22.
While it is clear fromsynovial ﬂuid analysis of aggrecanpro-
teolytic products that aggrecanase activity is enhanced at all
stagesof humanOA23 it is not yet knownwhichADAMTSsare
involved or how this activity is controlled. Localized cartilage
destruction suggests that gradients of proteolytic activity are
generated within the tissue and an understanding of these
events will require detailed analysis of regulatory mecha-
nisms for these proteinases. In addition to transcriptional
control24, there are a range of posttranslational events
(pro-domain removal25, C-terminal truncation26) which have
been found to modify ADAMTS activity. In addition, the
ADAMTSs appear, like their inhibitor tissue inhibitor of metal-
loproteinases-3 (TIMP-3)27, to beuniquely tailored for binding
to cell-surface and matrix components through the glycos-
aminoglycan-binding motifs present in the C-terminal do-
mains28,29. This may be particularly important in cartilage
destruction where glycosaminoglycans such as chondroitin
sulfate, keratan sulfate and hyaluronan (HA) represent major
matrix components. In this paper we have used confocal im-
munostaining and biochemical analysis to examine the rela-
tionship between the ADAMTS aggrecanases, aggrecan
cleavageproducts andHA in humancartilage tissueobtained
at surgery for OA. The results show that ADAMTS5 is
uniquely associated with HA in peri- and intercellular loca-
tions within clonal groups of cells, which are also the sites
of the most intense staining for the terminal aggrecanase
product, G1-NITEGE392.
Methods
CHEMICALS AND ANTIBODIES
Paraplast Tissue Embedding medium was from Tyco
Healthcare Group (www.kendallhq.com). Histology grade
xylene, 37e40% formalin, Superfrost/Plus slides and Har-
ris-modiﬁed hematoxylin (containing acetic acid) were
from Fisher Scientiﬁc. Streptomyces hyaluronidase was
from Seikagaku Inc., Western blot and confocal imaging
supplies were obtained as described30. All other chemicals
used were of the highest purity available. General details of
the histological and immunohistochemical methods have
been published30. Brieﬂy, antibodies NIT, KNG and VMA
(see Table I for details of all antibodies used in this paper)
have been previously characterized with respect to speciﬁc-
ity and cross-species reactivity by Western blots5,28,31e38.
Antibodies DLS, FDG, HNE, YNA and HST were raised in
rabbits against the ovalbumin-conjugated peptides in col-
laboration with Afﬁnity BioReagents, Golden, CO. All anti-
bodies used in this study were afﬁnity puriﬁed against
their cognate peptides on Sulfolink (Pierce, Rockford, IL)
and used at concentrations between 1 and 10 mg/ml. On
Western analysis, antibody HNE detected both 105 and
68 kDa forms of ADAMTS1 (METH-1) and antibody YNA
detected the 98 kDa form of ADAMTS8 (METH-2). Re-
combinant ADAMTS1 and ADAMTS8 (from transfected
293T cells) were kindly provided by Dr Luisa Iruela-Arispe.
Antibody FDG detected both recombinant forms (50e90
kDa) of ADAMTS9 in transfected HEK-293 cells (kindly pro-
vided by Dr Suneel Apte, Cleveland Clinic Foundation) and
HST detected a single recombinant construct of 60 kDa
(TS15-Cat-Dis-TSR1-Cys-FLAG) in transfected EBNA cells
(kindly provided by Dr N. Yamaji, Yamanouchi Pharmaceu-
tical Co.).AGGRECAN WESTERN ANALYSIS
Tibial plateaus were from four total left knee replacement
surgeries (73-year male, 69-year female, 75-year female,
82-year female), all diagnosed with OA (tissue, Grades 2e5
on theOsteoarthritisResearchSociety International (OARSI)
scale9). Normal femoral condylar cartilage was provided by
Dr Peter Roughley (Shriners Hospital, Montreal), and was
obtained at autopsy from four individuals (83-year male, 60-
year female, 59-year female, 29-year male) with no recorded
history of joint disease. Tissues were washed in phosphate-
buffered saline (PBS) (containing proteinase inhibitor cock-
tail) and stored at 80C. OA cartilages (Grades 2e4 tissue
pooled frommedial and lateral surfaces) and normal cartilage
were washed in ice-cold phosphate-buffered saline (PBS)
(þproteinase inhibitors), and 200 mg wet weight of tissue
was sliced into 3 mm 1 mm discs followed by extraction in
4 M guanidineHCl (þproteinase inhibitors), 50 mM sodium
acetate, pH 7.3, puriﬁed by G50 and DE52 chromatography
as described5 and deglycosylated core protein from 75 mg
dimethylmethylene blue-glycosaminoglycan (DMMB-GAG)
was loaded per lane.
ADAMTS WESTERN ANALYSIS
Extracts were prepared from ﬁve separate pools of OA
cartilage from lateral and medial tibial surfaces taken at total
knee arthroplasty. Patients were of both sexes and were
between 59 years and 78 years of age at the time of sur-
gery. The tissues (Grades 2e5 on the OARSI scale9)
were frozen in liquid nitrogen, powdered with a Bessman
Tissue Pulverizer, mixed with 50 mM Tris, 100 mM NaCl,
pH 7.0 (þproteinase inhibitors) (3 ml/g tissue) and extracted
gently at 4C for 2 h. Extracts were clariﬁed by centrifuga-
tion, the supernatant was added to 3 volumes of absolute
ethanol, stored at 20C for 2 h and precipitates were re-
covered by centrifugation. Pellets were washed with etha-
nol, and dissolved in 0.1 M ammonium acetate, 4 mM
ethylenediamine tetraacetic acid (EDTA), 0.1 mM 4-(2-Ami-
noethyl) benzenesulfonyl ﬂuoride (AEBSF), pH 6.0 (1 ml
per g tissue equivalent) for storage at 20C. For
ADAMTS4, 9 and 15 analysis portions (0.1 ml) were dried
and run on SDS-PAGE with and without digestion with
Streptomyces hyaluronidase. For ADAMTS5 analysis, por-
tions (0.5 ml) were dried in a Speedvac, dissolved in 4 M
guanidine/100 mM Tris/1 mM EDTA/pH 8.5 and reduced
and alkylated with 10 mM dithiothreitol (DTT) (2 h at 60C)
and 40 mM iodoacetic acid (20 h at room temperature
(RT)). Samples were fractionated on Superose 6
(1 cm 25 cm) in 0.5 M Na acetate, pH 6.5 at 12 ml/h col-
lecting 1.5 ml fractions. Material in fractions 4e21 was pre-
cipitated by addition of 3 volumes of absolute ethanol and
stored at 20C for 3 h. Pelleted protein was washed with
ethanol and dried brieﬂy. Portions were digested for 2 h at
37C in the presence or absence of Streptomyces hyaluroni-
dase or chondroitinase ABC as previously described5. The
products were solubilized in gel-loading buffer (with and
without DTT) and portions (equivalent to about 100 mg wet
wt of tissue) were loaded for ADAMTS5 Western analysis.
IHC
OA human tibiae were obtained from total knee arthro-
plasty as a single piece, approximately 2 cm deep, contain-
ing all articular borders and osteophytes. Normal control
cartilages were obtained at autopsy from the medial side of
lateral femoral condyles as previously described39 of a
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Summary of antibodies used in this study. The peptides used for immunization have an N-terminal cysteine added for coupling purposes. The
residue numbers shown are taken directly from human sequences in www.ncbi.nlm.nih.gov/entrez
Three-letter antibody notation Protein detected Human peptide
antigen used for immunization
References for
antibody characterization
DLS (also JSCDLS) Aggrecan core CGGSGVEDLS1411 See Footnote a
NIT (also JSCNIT) Aggrecan core CGGNITEGE392 5,28,36
HNE (also JSCHNE) ADAMTS1 CHNEFSKASFGSGPA642 This paper
VMA (also JSCVMA) ADAMTS4 CVMAHVDPEEP403 28,38
KNG (also JSCKNG) ADAMTS5 CKNGYQSDAKGVKTF649 37,42
YNA (also JSCYNA) ADAMTS8 CYNAYNYTDMDGNLL608 This paper
FDG (also JSCFDG) ADAMTS9 CFDGKHFNINGLLPN670 This paper
HST (also JSCHST) ADAMTS15 CHSTNRLTLAVAW603 This paper33-yearmale, a 50-yearmale and a 41-year female. The suit-
ability of femoral cartilage as a normal control in this study is
supported by the ﬁnding40 that important cell biological pa-
rameters (such as chondrocyte volume, chondrocyte surface
area, the number of cells per chondron, the matrix volume
per chondron and the number of chondrons per unit volume)
are essentially the same at all sites within the human knee
joint. All cartilages remained attached to the sub-chondral
bone to prevent swelling-induced morphological changes,
the specimens were rinsed brieﬂy with sterile saline, placed
in neutral-buffered formalin and ﬁxed for a minimum of 4
days. Tissues were suspended in gauze and decalciﬁcation
performed in 14% (w/v) EDTA/PBS for 7 weeks. Each OA
plateau with underlying bone attached was cut into 28 pieces
by dissection through the midline and then at 13 equidistant
locations from anterior to posterior across the medial and
lateral aspects. Individual pieces were decalciﬁed for an
additional 4 weeks in EDTA, equilibrated into 70% ethanol,
processed and embedded in parafﬁn.
IHC probes were individually optimized for sensitivity,
speciﬁcity and reproducibility. Thin (4 micron) sections
were deparafﬁnized as described30 and incubated in dilute
goat serum (1.5% v/v in PBS) for 20 min, prior to exposure
to speciﬁc IgGs, diluted to 1, 2, 5 and 10 mg/ml with 1.5% (v/v)
goat serum for 30 min at RT. IgG solutions were removed,
and sections were washed extensively in PBS before incu-
bation at RT for 30 min with 7.5 mg/ml biotinylated goat anti-
rabbit IgG (Vector labs). Sections were rinsed in PBS and
then treated with 3% hydrogen peroxide (v/v) in tap water
for 10 min, rinsed again in PBS, and incubated with horse-
radish peroxidase (HRP) labeled avidinebiotin complex
(Vector labs) for 30 min at RT, washed with PBS and then
incubated with 3,30-diaminobenzidine (DAB) substrate for
30 min. Negative controls (background staining) for each
antibody were established by omission of primary antibody,
and incubation with nonimmune rabbit IgG at the same con-
centration and under the same conditions. Speciﬁcity was
independently established by Western analysis with human,
bovine and recombinant antigens and antigenic peptide
blocking experiments5,30,36,41e43.
The sensitivity was determined by titration (0.1e20 mg/ml
IgG) and the concentration generating the maximum differ-
ential of immune IgG over nonimmune was chosen for sub-
sequent confocal IHC. For aggrecan epitopes, differential
reactivity was evident without antigen retrieval. In contrast,
ADAMTS4, 5, 9 and 15 protein epitopes in both normal
and OA cartilage required antigen retrieval by proteinase
K digestion as previously described in detail30. Staining
with anti-ADAMTS1 and anti-ADAMTS8 antibodies did not
generate signals, which could be readily distinguished
from nonimmune control on either normal or OA sections
either before or after proteinase K treatment, so theseenzymes were not further analyzed. It should be noted
that proteinase K treatment of cartilage sections also en-
hanced HA staining, consistent with removal of HA-bound
proteins from HA and provision of additional sites for hyalur-
onan binding protein (HABP) binding. This result is illus-
trated in Supplementary Fig. 1.
For confocal ﬂuorescent imaging, sections were stained
with primary antibodies as described above, washed in
PBS for 5 min and then incubated with AlexaFluor568
goat anti-rabbit IgG (1:250) for 1 h at RT. Sections were
also co-stained for HA as previously described30 using an
established method44, in which the G1 domain of bovine ag-
grecan was puriﬁed, modiﬁed with the EZ-link Sulfo-NHS-
LC-biotinylation kit (Pierce Inc.) and added to sections at
a dilution of 5.0 mg/ml PBS for 3 h at RT. Sections were
washed in PBS for 5 min and incubated with Alexa-
Fluor488-streptavidin for 1 h at RT. Sections were washed
with PBS, incubated with nuclear stain TOTO-3 (T3604,
Molecular Probes Inc., diluted 1:500 in PBS), covered
with Vectashield mounting medium (Vector Labs) and
imaged on a Leica TCS SP2 Confocal Scanning Laser
Microscope at a resolution of 1024 1024 pixels. Green
ﬂuorescence was detected between 498 and 560 nm after
excitation at 488 nm (using Ar/Kr laser source), red ﬂuores-
cence between 572 and 632 nm after excitation at 561 nm
(using He/Ne laser source) and blue ﬂuorescence between
649 and 690 nm after excitation at 633 nm (using He/Ne
laser source). Image analyses were performed using Leica
Confocal Imaging software, including visualization and ver-
iﬁcation of molecular level co-localized ﬂuorophores as pre-
viously reported45e47.
To conﬁrm speciﬁcity of HA staining, sections were
treated at 37C for 20 min with Streptomyces hyaluronidase
(2 U/ml) and washed extensively in PBS before application
of biotinylated G1 domain.
Results
HISTOPATHOLOGY OF HUMAN TIBIA CARTILAGE TAKEN AT
JOINT REPLACEMENT SURGERY
More than 30 tibial plateaus from patients with Stage 4
disease9 (entire joint surface involved) were examined to
establish general appearance and to select representative
samples for detailed analysis. Most samples retained carti-
lage on the lateral plateau, where peripheral osteophytes
were common. Consistent with commonly observed severe
knee OA, many had lost cartilage down to bone across the
middle of the medial compartment, but retained some carti-
laginous covering near the central ridge. The samples
analyzed in detail here (Fig. 1) were from the left knee of
722 A. Plaas et al.: ADAMTS5ehyaluronan complexes in OA cartilageFig. 1. Appearance and histopathology of tibial plateaus. The gross appearance of tibial plateaus from Patient 1 (58-year female) and Patient 2
(75-year female) are shown with the histological appearance (H and E) of representative samples taken from the area in the black box. The
H/E images show the range of histopathology present in this small area. S¼ superﬁcial zone; R¼ radial zone; T¼ transitional zone are
deﬁned as described40. M¼medial; L¼ lateral. See text for more details.a 58-year-old obese female (Patient 1, body mass index
(BMI) 49) and the right knee of a 75-year-old non-obese fe-
male (Patient 2, BMI 29). Patient 1 had bilateral knee OA
with no prior surgery and Patient 2 had prior total right hip
arthroplasty 4 years earlier.
The 28 parafﬁn mounts from each patient were sec-
tioned systematically from anterior to posterior to generate
mid-block sections, and stained with hematoxylin/eosin (H/E)
for histopathological evaluation on the OARSI grading
scale9. Sections shown were derived from within the small
black box shown on the medial aspect and reveal pathol-
ogies ranging from Grades 2 to 5 on the OARSI scale9.
The tibial surfaces from Patient 1 were severely degraded
with complete erosion on most of the medial aspect and
a large central erosion on the lateral side, with surrounding
deep ﬁbrillations. The medial surface was entirely ﬁssured
and there were clonal cell nests throughout the depth of
the tissue. The tibial surfaces from Patient 2 (lower panels)
appeared relatively intact except for a large focal lesion on
the anterior medial aspect. Histologically, the smooth ap-
pearing surfaces from this patient were rather acellular
and were covered with a ﬁbrous layer (left hand, H/E
panel). To illustrate how the samples taken from Patients
1 and 2 (Fig. 1) are representative of the whole patient
group we have also provided H/E images (10 per patient)
from Patients 3e6 (Supplementary Fig. 2) and H/E images
(four per patient) from Patients 1e4 (Supplementary
Fig. 3).ANALYSIS OF AGGRECAN SPECIES IN NORMAL AND OA
CARTILAGES BY IHC AND WESTERN BLOT
The three-letter notations, peptide epitopes and refer-
ences to production and characterization of all antibodies
used in this study are provided in Table I. To optimize con-
ditions for immunohistochemical analysis of full-depth hu-
man cartilages we examined effects of the decalciﬁcation
method (EDTA and formic acid), the parafﬁn formulation
and slide surface chemistry as previously described30. Us-
ing these optimized conditions, normal and OA sections
were stained with nonimmune IgG, DLS or NIT and exam-
ined by light microscopy with DAB visualization (Fig. 2, nor-
mal cartilage (top panels), OA cartilages (bottom panels)).
It is clear that some DAB staining was obtained with the
10 mg/ml nonimmune IgG used here. This was seen as a dif-
fuse matrix staining in the superﬁcial zone of the normal
cartilage and both matrix and cellular staining in the OA
cartilages. However, both immune probes showed an in-
creased intensity and altered distribution of staining which
we interpret as speciﬁc for the aggrecan epitopes. Thus, in
normal tissue DLS staining was seen throughout the full
depth of the section, predominantly associated with cells or
the cell-associated matrix. NIT staining in normals was vari-
able but largely limited to the cell-associated and interterrito-
rial matrix in the superﬁcial zone. It was also detected with
a few cells in the radial zone at the cartilageebone
interface. In OA, DLS staining intensity was generally
723Osteoarthritis and Cartilage Vol. 15, No. 7Fig. 2. Immunostaining and Western analysis of normal and OA cartilages for aggrecan epitopes. IHC of normal (41-year female) and OA
(Patient 1) cartilages. Shown are three different areas for each patient, representing Grade 1 tissue for the normal and Grades 2, 3.5 and
5, respectively, for the OA patient. A comparison of images obtained with nonimmune IgG (left hand IHC panels), anti-DLS (middle IHC
panels) and anti-NIT (right-hand IHC panels) are given. Western analyses of aggrecan epitopes, DLS and NIT, for four normal and four
OA patients (tissue, Grades 2e5) are also shown on the right. The bands shown here represent the only DLS- and NIT-reactive species pres-
ent in these samples. See text and Table I for the explanation of epitope designations (DLS, NIT), sample preparation and histological pro-
cessing of tissues. The molecular weight markers are for laminin A (400 kDa), myosin (250 kDa) and glutamic dehydrogenase (64 kDa).
S¼ superﬁcial zone; R¼ radial zone; T¼ transitional zone.increased and thiswasmost evident in the intercellularmatrix
of the transitional zone and in the pericellular matrix of the
radial zone. The NIT staining was also clearly increased and
more widely distributed in the OA tissue but this was conﬁned
to the intercellular matrix in the transitional zone. To illustrate
how the samples taken from Patient 1 for analysis of NIT
andDLS (Fig. 2) are representative of thewhole patient group,
we have also provided further NIT staining (four per patient) of
Patients1e4 (Supplementary Fig. 4) and furtherDLSstaining
(four per patient) of Patients 1e4 (Supplementary Fig. 5).
As expected from the IHC, Western analysis of aggrecan
core species in preparations from four normal and four OA
patients (Fig. 2, right side) gave strong signals with both
DLS and NIT probes. Other studies with anti-G1 domain
antibodiesa show that DLS reacts with both full-length ag-
grecan (upper band above the 400 kDa marker) and a major
C-terminally truncated aggrecan population (at about
250 kDa) which can be generated by m-calpain digestion
and which is a normal constituent of human cartilages (refe-
rred to as band a in Refs. 5 and 34). Interestingly, the
aDetails of the DLS antibody and the human aggrecan species
which it detects in human cartilage extracts and synovial ﬂuids
are provided in a manuscript in review.76present data from both Westerns and immunostaining indi-
cate that OA cartilages contain more abundant DLS-
reactive products and a higher ratio of full-length molecules
to C-terminally truncated molecules, consistent with our
data from joint injury patients5. The similar, albeit variable,
reactivity with NIT in normal and OA cartilage extracts on
Western is expected5, suggesting that the consistently
increased staining with NIT in the OA tissue sections
(Fig. 2) is due to enhanced antigen accessibility, and not
increased accumulation of NIT epitope. The variability of
signal between patients on Westerns is probably due to
the fact that heterogeneous tissue, which had been pooled
from medial and lateral surfaces of the tibia of each patient,
was used for extraction (see Methods).
When the normal and OA samples described by IHC in
Fig. 2 were analyzed by multichannel ﬂuorescence confocal
microscopy (Fig. 3) the data were supportive of the DAB
results but much more deﬁnitive. Most notably, the nonim-
mune IgG background staining was essentially undetect-
able and the immune staining for both DLS and NIT
was very clear. In addition the enhanced staining of the
aggrecan epitopes in the OA tissue was found at 63
(right-hand panels) to be largely intracellular for DLS
whereas NIT was both intracellular and matrix-associated.
724 A. Plaas et al.: ADAMTS5ehyaluronan complexes in OA cartilageFig. 3. Confocal imaging of normal and OA cartilage co-stained for aggrecan epitopes and hyaluronan. Contiguous sections of normal cartilage
from a 41-year female (top panels) and OA cartilage from Patient 1 (Grade 3.5, bottom panels) were probed with either nonimmune IgG, DLS
or NIT as shown, and co-stained for HA and nuclei. Confocal images of individual antibody (Ab) stains for protein (red), HABP for HA (green)
and TOTO-3 for nuclei (blue), as well as automated overlays of low magniﬁcation (10) are shown. High magniﬁcation images of overlays for
DLS and NIT staining in superﬁcial (S) and transitional (T) cell groups are also shown.Additionally the overlay analysis shows that the HA and ag-
grecan epitope staining are not co-localized, which would
be explained if the HABP probe does not readily detect
HA in the presence of high and competing concentrations
of cross-linked and HA-bound aggrecan species. The over-
lay analysis also shows that HA staining can be readily de-
tected in OA cartilage only and in that tissue it is restricted
to the superﬁcial and upper transitional zones. This may
represent a pool of HA that is readily accessible to the
probe due to low concentrations of tissue aggrecan at these
degenerating locations (also see Supplementary Fig. 1).
ANALYSIS OF ADAMTSs BY IHC
Attempts to detect ADAMTS proteins in untreated tissue
sections, under conditions used for aggrecan probes in IHC
(Figs. 2 and 3), were unsuccessful, suggesting that ADAMTS
epitopes were masked by other matrix components. Most
antigen retrieval methods (heat treatment in Tris or citratebuffers, chondroitinase or hyaluronidase digestions) gave
no improvement, however, a mild and controlled digestion
with proteinase K enabled speciﬁc staining to be studied.
This effect is illustrated in Fig. 4 (left panels) where staining
of normal cartilage with KNG (ADAMTS5) is shown. When
this protocol was applied to OA cartilages (Fig. 4, right
panels), some background staining with nonimmune IgG
was found, however, marked enhancement was seen in
matrix staining for VMA (ADAMTS4) and in cell staining for
KNG (ADAMTS5). Indeed, IHC analyses of OA cartilages
with KNG showedmarked increases in cell-associated stain-
ing for ADAMTS5 protein in the superﬁcial and transitional
zones of all diseased cartilage sections examined.Moreover,
the increased staining was most evident for clonal nests of
chondrocytes in the severely degenerate regions of the tis-
sue, whereas minimal or no staining for KNG was seen in
the radial zone cells (data not shown). VMA staining was
essentially undetectable in normal cartilages (see also
Fig. 8) and was enhanced in the matrix of OA tissues.
725Osteoarthritis and Cartilage Vol. 15, No. 7Fig. 4. Immunostaining with DAB of normal and OA cartilages for ADAMTS4 and 5. Normal cartilages from a 41-year female (left panels) taken
from superﬁcial (S), transitional (T) and radial (R) zones were stained with KNG with or without proteinase K treatment for antigen unmasking.
OA cartilages (right panels, Grades 2, 3 and 4 from Patient 2) were proteinase K treated and stained with 10 mg/ml of nonimmune IgG, VMA
(ADAMTS4) or KNG (ADAMTS5).To further examine the organization of the enhanced
staining of ADAMTS5 in OA tissues, KNG staining was
next examined by confocal imaging (Fig. 5). As expected
from the DAB data (Fig. 4) the cell-associated staining of
ADAMTS5 was dramatically increased in OA relative to nor-
mal cartilage (left hand images, Figs. 5e7). Most strikingly,
co-localization analyses with HABP showed abundant
association of ADAMTS5 with HA surrounding cells in the
superﬁcial region of normal cartilage and in both the super-
ﬁcial and transitional regions of OA cartilages (indicated by
white arrows, Figs. 5 and 6).
High magniﬁcation images of the cell-associated staining
of the protease and HA (Figs. 6 and 7) revealed additional
details of the spatial organization of the complexes. In the
superﬁcial zone of normal, and in both zones of OA carti-
lage, the immunoreactive enzyme was predominantly extra-
cellular and appeared as a ‘‘coat’’-like structure, 1e3
microns thick, surrounding much of the cell. These HAe
ADAMTS5 complexes, however, were not uniformly distrib-
uted around cells, but were seen as patchy foci localized
along the periphery of individual cells in clonal groups
(Figs. 6 and 7, white arrows). Notably, ADAMTS5 staining
of cells in the transitional (Fig. 6) and radial (data not shown)
zones of the normal cartilage was minimal; such immunore-
active enzyme was largely intracellular and no detectable
co-localization with HA was seen (Fig. 6). To illustrate howthe data in Figs. 6 and 7 are representative of the whole
patient group under study we have provided further co-
localization analyses of ADAMTS5 and HA in both normal
and OA patients (Supplementary Figs. 6 and 7).
Co-localization analyses of ADAMTS4 (Fig. 8) and
ADAMTS9 (Fig. 9) with HA provided no evidence for any
complexes between these two proteases and HA.
ADAMTS4 was not detected in normal cartilage, but was
detectable as diffuse extracellular matrix staining at the sur-
face of the OA cartilage, in general agreement with the DAB
data shown in Fig. 4. ADAMTS9 staining (abundance and
distribution) was similar in all zones of normal and OA car-
tilages (Fig. 9), showing a predominant intracellular or cell-
associated ﬁlamentous distribution pattern. Interestingly,
the compact cell-associated organization of this ‘‘network’’
in normal chondrocytes appeared to be modiﬁed in most
of the OA cells in which there was a frequent occurrence
of ADAMTS9-positive extensions protruding from the cell
into the matrix (Fig. 9, white arrows).
WESTERN ANALYSIS OF ADAMTS PROTEINASES
IN OA CARTILAGE
In order to examine the nature of the molecular forms of
ADAMTS4, 5, 9 and 15 in human OA cartilages we carried
out Western analysis on ﬁve separate preparations of
726 A. Plaas et al.: ADAMTS5ehyaluronan complexes in OA cartilageFig. 5. Confocal imaging of normal and OA human cartilage co-stained for ADAMTS5 and HA. Cartilage sections (Grade 3.5) from OA Patient
1, OA Patient 2 and a normal 41-year female are shown. Each section was stained with KNG for ADAMTS5 (red), the HABP probe for HA
(green) and TOTO-3 for nuclei (blue). Superﬁcial (S) and transitional (T) regions of the sections were imaged by confocal microscopy. The left
hand images show the protein stain only, and the right-hand images show the automated overlays (redþ greenþ blue ﬂuorescence) gener-
ated for each section. Areas appearing as yellow/orange indicative of GAGeprotein co-localization are highlighted by the white arrows in each
panel. Selected cell groups from such areas were examined at higher magniﬁcation and are shown in Figs. 6 and 7.extracts of pooled OA tibial cartilages with and without
digestion with Streptomyces hyaluronidase (see Methods
for details). Crude extracts run under reducing conditions
showed that ADAMTS4 was present as the expected p68
and p53 forms previously described28, and this pattern
was not altered by hyaluronidase digestion. ADAMTS9
was detected as a single species (about 60 kDa) and
ADAMTS15 as two species (about 60 and 68 kDa) and nei-
ther pattern was altered by hyaluronidase digestion (data
not shown).
A detailed Western analysis of ADAMTS5 protein in
these extracts was undertaken next. This showed that
digestion with Streptomyces hyaluronidase markedly in-
creased the abundance of ADAMTS5 protein entering
the gel, and also that the detection of ADAMTS5 with
antibody KNG was markedly improved by electrophoresis
under native conditions (without DTT reduction). To inves-
tigate the nature of the Streptomyces hyaluronidase-sensi-
tive material, crude undigested extract was fractionated on
Superose 6 and analyzed by Western blot for ADAMTS5
without reduction. The yield of high molecular weight com-
plex (Kav 0e0.3) was low (see below for high yield proce-
dure) and the majority of the recovered ADAMTS5 was
eluted from Superose 6 with a Kav of about 0.6 andappeared as a 150 kDa complex on SDS-PAGE (for de-
tails see Discussion). In order to improve the recovery of
the HAeADAMTS5 complex from Superose 6, crude ex-
tracts were reduced and alkylated prior to chromatography
to eliminate nonspeciﬁc proteineprotein and proteineGAG
interactions. Following this pretreatment, a low yield of 60
and 30 kDa ADAMTS5 species were found to be eluted
from Superose 6, peaking in fractions 7e9 (Fig. 10, left
panel), with a trailing edge of the same composition in
fractions 10e12 (not shown). Most signiﬁcantly, when
these peak fractions were digested with Streptomyces hy-
aluronidase before sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) (Fig. 10, middle panel)
there was a very marked increase in the abundance of
ADAMTS5 protein at about 150 kDa (diffuse band),
60 kDa and particularly 40 kDa. These species were also
seen on digestion with Chase ABC, with an even higher
yield of the diffuse band above 150 kDa. These biochem-
ical data are consistent with the interpretation that
ADAMTS5 is present in human OA cartilage extracts in
multiple forms, all of which are sequestered in a HA-based
complex. Furthermore, such a complex can be readily iso-
lated for study by isotonic salt extraction and rapid chro-
matographic separation.
727Osteoarthritis and Cartilage Vol. 15, No. 7Fig. 6. High resolution ADAMTS5eHA co-localization in chondrocytes in normal cartilage. Representative cell groups from the superﬁcial (S),
and transitional (T) zones of normal cartilage sections stained with KNG (or nonimmune IgG) and co-stained with HABP were viewed at higher
magniﬁcation (63). KNG alone (red), HA alone (green) and overlays of the same cell group with KNG (red), HA (green) and nuclei (blue) are
shown. Regions of co-localization of ADAMTS5 and HA (yelloweorange, bottom panels) are indicated by white arrows. See text for more
details.Discussion
Because of the widespread use of total knee replacement
surgery, tissues from advanced disease are widely available
for analysis. Many studies, including the present report,
have focused on the ﬁssured and remodeled articular carti-
lage, which remains on the tibial surfaces. Histologic de-
scription of this tissue9 reports surface roughening, vertical
ﬁssures, surface delamination, cavity formation, tissue frag-
mentation and growth of ﬁbrocartilage. Biochemical analysis
has also revealed major changes in matrix composition and
cellular activity at both the anabolic48 and catabolic49 levels.
Cellular changes are primarily described as development of
clonal nests, although there is considerable debate over
whether these cells are derived from the original ‘‘quiescent’’
articular chondrocyte population by trans-differentiation20 or
whether they aremigratory cells which enter from surrounding
tissues50,51.
While the mechanism by which these cells mediate the
chronic and irreversible ECM destruction in OA remains
unclear, there appears to be a general consensus that
they represent the ‘‘osteoarthritic’’ cell, which is responsible
for the progressive deterioration of the tissue. In this regard
there is also consensus that ADAMTSs (such as ADAMTS4/
aggrecanase-1 or ADAMTS5/aggrecanase-2) are responsi-
ble for destruction of the aggrecan matrix22 whereas MMPs
(such as MT1-MMP and MMP-13) destroy the collagenmatrix52. On the other hand, there is no detailed information
on temporal and spatial aspects of metalloproteinase abun-
dance in OA development and little is known about how the
different proteinase cascades may interact in space and
time, to accelerate or limit matrix destruction. We report
here data obtained from confocal immunohistochemical
imaging of thin sections of full-depth human knee cartilage
tissue, and in combination with established biochemical
studies, this approach represents a new framework for stud-
ies of this area.
In the present study, ADAMTS5 (but not ADAMTS1, 4, 8,
9, and 15) was found to co-localize with HA around isolated
cell groups in the superﬁcial zone of normal adult cartilage
and most strikingly around cells of clonal nests in OA carti-
lage. This co-localization in situ was reﬂected in the pres-
ence of an ADAMTS5eHA complex in tissue extracts
(Fig. 10). This complex was isolated using Superose 6 chro-
matography of reduced and alkylated cartilage extracts,
eluting with a Kav w0.3, consistent with a molecular size
of about 2 106. Stability of the complex to reduction and
alkylation suggests that the capacity of ADAMTS5 to bind
HA does not depend on globular protein structures
maintained by disulﬁde bonding, but rather short linear
peptide sequence such as the double HA-binding motif
(Fig. 10). The puriﬁed complex was found to contain
ADAMTS5 in multiple molecular forms (150, 60, 40 kDa),
all of which were released by digestion with Streptomyces
728 A. Plaas et al.: ADAMTS5ehyaluronan complexes in OA cartilageFig. 7. High resolution ADAMTS5eHA co-localization in chondrocytes in the superﬁcial zone of OA cartilage (Patient 1). Representative cell
groups from the superﬁcial (S) and transitional (T) zones’ sections of OA cartilage (Patient 1) stained with KNG (or nonimmune IgG) and co-
stained with HABP were viewed at higher magniﬁcation (63). KNG alone (red), HABP alone (green) and overlays of the same cell group with
KNG (red), HA (green) and nuclei (blue) are shown. Regions of co-localization of ADAMTS5 and HA (yelloweorange, bottom panels) are in-
dicated by white arrows. HA-free areas’ staining for KNG are indicted by (*). See text for more details.hyaluronidase or chondroitinase ABC. A 55 kDa ADAMTS5
species has previously been characterized by us employing
IHC and Western analysis of murine cumulus oocyte com-
plexes with antibody KNG37.
The major ADAMTS5 species released by HA digestion
was a 40 kDa form which would appear to represent the
fully activated form of the proteinase53, processed by pro-
domain removal and C-terminal truncation to remove the
TSR2, spacer domain and much of the Cys-rich domain
(see Fig. 10 diagram). The precise C-terminal of this spe-
cies is unknown, however, by comparison with SDS-
PAGE migration of recombinant forms53 it would appear
to be near the boundary of the TSR1 and Cys-rich domains.
The ﬁnding that it is detected by antibody KNG (residues
636e650) shows that the protein must include these resi-
dues and it therefore appears to represent the ADAMTS5
equivalent of the highly active p40 form of ADAMTS4 which
is generated by autocatalytic and MT4-MMP-mediatedremoval of the spacer and Cys-rich domains26. The
diffusely migrating ADAMTS5-positive product of about
150e200 kDa might retain undigested HA oligosaccharide
which might be explained if the binding proteins prevent
complete HA cleavage. In this regard it is interesting that,
in addition to ADAMTS5, this species contains a 65 kDa
form of heavy chain 254 (Plaas and Yoshihara, unpub-
lished), a ﬁnding which appears to be related to the pres-
ence of SHAP (heavy chaineHA) complexes in the
synovial ﬂuid of RA patients55.
The discovery here of a complex of HA andADAMTS5 (but
not ADAMTS1, 4, 8, 9, 15) is consistent with theGAG-binding
motifs present within the C-terminally truncated forms of
these proteinases (see Fig. 10). On the basis that a BX7B
motif confers HA binding56 whereas an XBBXBX motif con-
fers heparin binding57, there are four potential binding sites
present in the aggrecanases, two contiguous HA-binding
motifs within the disintegrin domain, and two separated
729Osteoarthritis and Cartilage Vol. 15, No. 7Fig. 8. ADAMTS4eHA co-localization in chondrocytes in the superﬁcial zone of normal and OA cartilage. The localization of ADAMTS4 in
relation to HA was examined in cell groups from the superﬁcial (S) and transitional (T) zones in sections of normal and OA cartilages.
VMA alone (red), HABP alone (green) and overlays of the same cell group with VMA (red), HA (green) and nuclei (blue) are shown.heparin-binding motifs within the thrombospondin and
spacer domains. ADAMTS5 is unique in containing both
HA-binding motifs (544KGRICLQGKCVDKTKKK559) within
the disintegrin domain, consistent with a high afﬁnity for HAof
all molecular forms including the activated p40 form which is
so abundant in the isolated complexes. It is also worth men-
tion that human TIMP-3, a potent inhibitor of the aggreca-
nases58 has three BX7B HA-binding motifs.
It should also be noted that the ADAMTS5eHA com-
plexes were conﬁned to speciﬁc regions of the pericellular
HA coat (Figs. 6 and 7), and this is consistent with a regu-
lated assembly of this complex. This may occur in associa-
tion with cellular dynamics, such as proliferation, migration
and cellecell or cellematrix adhesion in the formation of
clonal nests. In this regard it may be relevant that speciﬁ-
cally structured HA matrices are generated at many pericel-
lular locations involving response to stresses such as
viral59, oxidative60 and inﬂammatory insult61. The formation
of these HA complexes requires TSG-662, which is also
found in high abundance by immunostaining within the
clonal nests of OA cartilages (Plaas, Osborn and Sandy,
unpublished). In this regard, the TSG-6-mediated formationof an HA complex capable of sequestering ADAMTS5 pro-
tein and HC2 may explain the chondroprotective effect of
TSG-6 overexpression in murine inﬂammatory arthritis63.
The formation of such proteinaseeHA complexes in
human cartilage could also be protective against aggreca-
nase-mediated tissue destruction. This would be analogous
to the role played by HA in protecting the integrity of the peri-
cellular environment of airway epithelium by sequestering
kallikrein and lactoperoxidase, whose rapid actions at select
sites are nonetheless necessary to maintain tissue homeo-
stasis64. On the other hand, it is possible that persistent
and/or excessive accumulation of such proteinaseeHA com-
plexes in clonal nest inOA cartilage, followed by uncontrolled
dissolution of the HA through hyaluronidase activity65 or oxy-
radical cleavage66 releases the p40 form of ADAMTS5 and
generates the pathological activity that results in progression
of murine OA67 and also possibly human disease.
Clearly, more work is needed to determine whether the
co-localization of ADAMTS5, but not ADAMTS1, 4, 8, 9
and 15, with HA in human OA cartilage represents evidence
that ADAMTS5 is the destructive aggrecanase in this
tissue. Our antibody design and characterization suggests
730 A. Plaas et al.: ADAMTS5ehyaluronan complexes in OA cartilageFig. 9. ADAMTS9eHA co-localization in chondrocytes in the superﬁcial zone of normal and OA cartilage. The localization of ADAMTS9 in
relation to HA was examined in cell groups from the superﬁcial (S) and transitional (T) zones in sections of normal and OA cartilages.
FDG alone (red), HABP alone (green) and overlays of the same cell group with FDG (red), HA (green) and nuclei (blue) are shown.
Fig. 10. Western analysis of the HAeADAMTS5 complex isolated from OA cartilage and the location of GAG-binding motifs in the different
enzymes. Isotonic salt extract of human OA cartilages was reduced and alkylated for Superose 6 chromatography. Fractions were character-
ized by Western analysis under nonreducing conditions with antibody KNG. Only data from peak fractions 7e9 are shown. Samples were
loaded undigested or after digestion with Streptomyces hyaluronidase or Chase ABC. The schematic shows the location and presence
(þ) or absence () of HA-binding (BX7B) and heparin-binding (XBBXBX) motifs in human ADAMTS4, 5, 9 and 15. Also shown are the location
of the KNG epitope for ADAMTS5 and the predicted structures of the 60 and 40 kDa forms of ADAMTS5. See text for more details.
731Osteoarthritis and Cartilage Vol. 15, No. 7that the lack of staining for ADAMTS1 and ADAMTS8 is not
due to poor quality antibodies but due to the low abundance
of these aggrecanases in the human cartilage specimens
studied here. In this regard, it should be noted that the
antibodies to ADAMTS1 (HNE), ADAMTS5 (KNG),
ADAMTS8 (YNA), ADAMTS9 (FDG) and ADAMTS15
(HST) were all raised against ‘‘equivalent’’ peptides located
at the same site at the N-terminal end of the Cys-rich do-
main of the respective proteins. This region shows very little
sequence similarity between these ﬁve aggrecanases and
so peptides at this location can be used to generate mem-
ber-speciﬁc antibodies. We also have an anti-ADAMTS4
antibody to this region (YNH)28, however, the ADAMTS4
antibody (VMA)28 used in the present study was raised
against a sequence in the catalytic domain. While the rela-
tive reactivities of these anti-ADAMTS IgGs for their cog-
nate epitopes have not been determined, all antibodies
readily detected the recombinant proteins on Western anal-
ysis which were loaded on gels at equivalent volumes
(50 ml) of conditioned medium from the transfected cells.
With respect to which aggrecanase is most important in
the pathology of human OA, Wachsmuth et al.68 have ex-
amined ADAMTS1 abundance in normal and OA human
cartilages and have concluded that ADAMTS1 is not re-
sponsible for pathological aggrecanolysis. Malfait et al.69
studied ADAMTS enzyme abundance and the effects of
ADAMTS inhibitors on aggrecanolysis in human cartilage
explants and concluded that both ADAMTS4 and ADAMTS5
are responsible. Demircan et al.70 compared the IL-1-
inducibility of ADAMTS1, 4, 5, 8, 9 and 15 in human
chondrocytes and showed that ADAMTS9 is most readily
induced and therefore may be responsible for human carti-
lage pathology. An important question for future study in this
area is the identiﬁcation of biologically relevant substrates
for the aggrecanases. While most work has focused on ag-
grecan degradation in cartilage it is also now clear that
these proteinases have activity in vivo against other sub-
strates in joint tissues such as versican V0/V141, COMP71
and alpha-2-macroglobulin72. The physiologic importance
of these activities, the effect of C-terminal truncation on
the activity and speciﬁcity of ADAMTS4 and ADAMTS5
and the control of ADAMTS4 and ADAMTS9 activity by
furin-mediated pro-domain removal73,74 also clearly repre-
sent important areas of investigation. On the other hand,
the present study further suggests that an understanding
of the role of HA in cartilage aggrecanolysis75 may provide
a deﬁnitive clue to the means of effective therapeutic control
of joint tissue destruction.
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